We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Membership and minutes for the Commission on Human Medicines (CHM) and its expert advisory groups (EAGs).
The home of Commission on Human Medicines on GOV.UK. The Commission on Human Medicines (CHM) advises ministers on the safety, efficacy and quality of medicinal products.
Independent report by the Commission on Human Medicines on the safety implications of a proposal to restrict the availability of puberty blockers for under 18s.
This report was finalised by the Commission on Human Medicines on 13…
Report of Isotretinoin Implementation Advisory Expert Working Group regarding recommendations to strengthen the safe use of isotretinoin, the acne medicine commonly known by brand names Roaccutane and Reticutan.
The Commission on Human Medicines (CHM) advises ministers on the safety, efficacy and quality of medicinal products.
Report of the Commission on Human Medicines (CHM) Isotretinoin Expert Working Group and plain-language summary of the recommendations.
The chance for adults and children suffering from life-threatening allergic reactions to get life-saving shots of adrenaline in public places, such as restaurants and entertainment venues, has come a step closer as a result …
Nine new commissioners have been appointed to the Commission on Human Medicines to serve for four years, in accordance with the Cabinet Office Code of Governance for Public Appointments.
Expert Working Group concludes there is currently insufficient evidence to establish a link between use of ibuprofen and susceptibility to contracting COVID-19 or the worsening of its symptoms.
An Expert Working Group (EWG) of the UK’s Commission on Human Medicines (CHM) has published their report on the use of hormone pregnancy tests (HPTs) and adverse effects relating to pregnancy including possible birth defects.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).